Companies / Health Care / Health Care Supplies
West Pharmaceutical Services stock buybacks
WST$454Mbought back in the 12 months to Jun 30, 2026
West Pharmaceutical Services bought back $454M of its stock in the last twelve months, $422M more than it paid out in stock compensation. Its share count is down 1.7% from a year earlier.
Show as table
| Period | Value |
|---|---|
| Q3 '20 | $0 |
| Q4 '20 | $0 |
| Q1 '21 | $137.1M |
| Q2 '21 | $0 |
| Q3 '21 | $0 |
| Q4 '21 | $0 |
| Q1 '22 | $147.1M |
| Q2 '22 | $28.6M |
| Q3 '22 | $27.2M |
| Q4 '22 | −$100,000 |
| Q1 '23 | $60.1M |
| Q2 '23 | $173.4M |
| Q3 '23 | $27.8M |
| Q4 '23 | $177M |
| Q1 '24 | $267M |
| Q2 '24 | $187.1M |
| Q3 '24 | $52.4M |
| Q4 '24 | $54.4M |
| Q1 '25 | $133.5M |
| Q2 '25 | $500,000 |
| Q3 '25 | $0 |
| Q4 '25 | $0 |
| Q1 '26 | $297.6M |
| Q2 '26 | $156.7M |
Show as table
| Period | Value |
|---|---|
| Q3 '20 | 75.8M |
| Q4 '20 | 76.4M |
| Q1 '21 | 75.8M |
| Q2 '21 | 75.7M |
| Q3 '21 | 76.0M |
| Q4 '21 | 77.7M |
| Q1 '22 | 76.0M |
| Q2 '22 | 75.8M |
| Q3 '22 | 75.7M |
| Q4 '22 | 75.7M |
| Q1 '23 | 75.7M |
| Q2 '23 | 75.4M |
| Q3 '23 | 75.3M |
| Q4 '23 | 74.8M |
| Q1 '24 | 74.3M |
| Q2 '24 | 73.7M |
| Q3 '24 | 73.4M |
| Q4 '24 | 73.4M |
| Q1 '25 | 73.0M |
| Q2 '25 | 72.5M |
| Q3 '25 | 72.6M |
| Q4 '25 | 72.7M |
| Q1 '26 | 72.4M |
| Q2 '26 | 71.3M |
$157Mlast quarter (Q2 2026)
$422Mnet of stock compensation ($33M)
−1.7%diluted shares, 1 year
−4.1%diluted shares, 5 years
$62Mdividends, 12 months
104%of free cash flow ($437M) spent on buybacks
$0raised by issuing stock, 12 months
70.4Mshares outstanding (Jul 20, 2026)
Share counts are adjusted for a stock split (2-for-1).
By fiscal year
Questions
- Does West Pharmaceutical Services buy back its stock?
- West Pharmaceutical Services bought back $454M of its stock in the last twelve months, $422M more than it paid out in stock compensation. Its share count is down 1.7% from a year earlier.
- How much did West Pharmaceutical Services spend on buybacks in fiscal 2025?
- $134M, according to its 10-K for the fiscal year ending Dec 31, 2025.
- Is West Pharmaceutical Services's share count going down?
- Its diluted share count changed −4.1% over five fiscal years and −1.7% over the last year.
Latest filing used: 10-Q for the period ending Jun 30, 2026, filed Jul 23, 2026 · open on SEC.gov